AB0564 Continuation and remission rates of tocilizumab treatment based on improvement in patient global assessment: 2-year study based on the tsurumai biologics communication registry
Asai, N., Kobayakawa, T., Saito, K., Shioura, T., Yabe, Y., Kojima, T., Kaneko, A., Ishiguro, N.Volume:
71
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-eular.564
Date:
June, 2013
File:
PDF, 50 KB
english, 2013